Skip to main content

Table 1 Demographic characteristics

From: Association of glucose homeostasis measures with heart rate variability among Hispanic/Latino adults without diabetes: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

Characteristic

N

% or Mean

95 % CI

Male (%)

4833

48.11

(46.79, 49.42)

Age group (%)

 18–24

1444

18.94

(17.73, 20.21)

 25–34

1819

24.63

(23.25, 26.06)

 35–44

2461

23.03

(21.81, 24.30)

 45–54

3562

18.01

(17.03, 19.02)

 55–64

2106

10.34

(9.61, 11.12)

 65+

602

5.05

(4.47, 5.70)

Hispanic background (%)

 Mexican/Mexican American

4784

38.13

(34.90, 41.46)

 Puerto Rican

1809

15.09

(13.58, 16.74)

 Cuban

1753

19.61

(16.54, 23.08)

 Dominican

1084

10.02

(8.68, 11.55)

 Central American

1320

7.59

(6.48, 8.86)

 South American

854

5.28

(4.63, 6.02)

 Other

390

4.28

(3.68, 4.96)

Body mass index (BMI; kg/m2)

 

28.88

(28.68, 29.08)

Waist circumference (cm)

 

95.90

(95.44, 96.36)

Obese (BMI ≥ 30 kg/m2)

4597

36.86

(35.37, 38.38)

Abdominal adiposity

6818

51.44

(49.82, 53.05)

Systolic blood pressure (mmHg)

 

118.32

(117.85, 118.79)

Diastolic blood pressure (mmHg)

 

71.79

(71.43, 72.15)

Fasting glucose (mg/dL)

 

93.51

(93.28, 93.74)

Fasting insulin (mU/L)

 

12.06

(11.78, 12.34)

HbA1c (%)

 

5.41

(5.40, 5.42)

HOMA-IR (index)

 

2.83

(2.76, 2.90)

Current smoking

2382

21.86

(20.60, 23.17)

Coronary heart disease

416

3.19

(2.71, 3.75)

Self-reported heart failure

132

0.87

(0.68, 1.10)

Beta blocker use

520

3.24

(2.86, 3.66)

Non-hydropyridine calcium channel blocker use

300

1.98

(1.63, 2.41)

Sympathomimetic medication use

441

3.50

(3.01, 4.07)

  1. The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) baseline examination (2008–2011)
  2. Abdominal adiposity (waist circumference ≥102 cm for men and ≥88 cm for women)